谷歌浏览器插件
订阅小程序
在清言上使用

Translational Findings Support Regimen Selection for First-in-human Study of Ubamatamab (MUC16 X CD3 Bispecific Antibody) in Patients with Recurrent Ovarian Cancer

CTS-CLINICAL AND TRANSLATIONAL SCIENCE(2024)

引用 0|浏览2
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要